CXC chemokines in angiogenesis.

[1]  W. Isaacs,et al.  Modulation of CXCL14 (BRAK) expression in prostate cancer , 2005, The Prostate.

[2]  Jürgen Schymeinsky,et al.  Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8. , 2005, American journal of physiology. Heart and circulatory physiology.

[3]  M. Burdick,et al.  CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. , 2005, American journal of respiratory and critical care medicine.

[4]  A. El‐Naggar,et al.  BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells , 2004, Cancer Research.

[5]  M. Burdick,et al.  Identification and Partial Characterization of a Variant of Human CXCR3 Generated by Posttranscriptional Exon Skipping1 , 2004, The Journal of Immunology.

[6]  M. Burdick,et al.  Platelets Release CXCL4L1, a Nonallelic Variant of the Chemokine Platelet Factor-4/CXCL4 and Potent Inhibitor of Angiogenesis , 2004, Circulation research.

[7]  M. Fujiki,et al.  IκBαM suppresses angiogenesis and tumorigenesis promoted by a constitutively active mutant EGFR in human glioma cells , 2004 .

[8]  M. Burdick,et al.  Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis , 2004, BMC Cancer.

[9]  M. Gershengorn,et al.  Insights into the viral G protein-coupled receptor encoded by human herpesvirus type 8 (HHV-8). , 2004, Biology of the cell.

[10]  A. Richmond,et al.  The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  R. Strieter,et al.  CXC chemokines in angiogenesis of cancer. , 2004, Seminars in cancer biology.

[12]  D. Bar-Sagi,et al.  Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. , 2004, Cancer cell.

[13]  R. Jain,et al.  The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis , 2004, Nature.

[14]  M. Burdick,et al.  Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer1 , 2004, The Journal of Immunology.

[15]  E. Lin,et al.  NF‐κB activity blockade impairs the angiogenic potential of human pancreatic cancer cells , 2004 .

[16]  M. Huang,et al.  EBV-Induced Molecule 1 Ligand Chemokine (ELC/CCL19) Promotes IFN-γ-Dependent Antitumor Responses in a Lung Cancer Model , 2003, The Journal of Immunology.

[17]  J. Hanna,et al.  Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice. , 2003, Blood.

[18]  W. Mitzner,et al.  Identification of genes promoting angiogenesis in mouse lung by transcriptional profiling. , 2003, American journal of respiratory cell and molecular biology.

[19]  M. R. Hellmich,et al.  Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. , 2003, Cancer research.

[20]  R. Salcedo,et al.  Role of Chemokines in Angiogenesis: CXCL12/SDF‐1 and CXCR4 Interaction, a Key Regulator of Endothelial Cell Responses , 2003, Microcirculation.

[21]  Sergio Romagnani,et al.  An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4 , 2003, The Journal of experimental medicine.

[22]  M. Burdick,et al.  The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. , 2003, American journal of respiratory and critical care medicine.

[23]  M. Huang,et al.  SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10 , 2003, Molecular Cancer.

[24]  D. Ota,et al.  Angiogenic Effects of Interleukin 8 (CXCL8) in Human Intestinal Microvascular Endothelial Cells Are Mediated by CXCR2* , 2003, The Journal of Biological Chemistry.

[25]  E. Tschachler,et al.  Kaposi's Sarcoma-Like Tumors in a Human Herpesvirus 8 ORF74 Transgenic Mouse , 2003, Journal of Virology.

[26]  M. Iannettoni,et al.  Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  Jeremy J. W. Chen,et al.  Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  D. Weigent.  Universes in Delicate Balance: Chemokines and the Nervous System , 2003 .

[29]  R. Bachelder,et al.  Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. , 2002, Cancer research.

[30]  M. Fishbein,et al.  Imbalance in the Expression of CXC Chemokines Correlates with Bronchoalveolar Lavage Fluid Angiogenic Activity and Procollagen Levels in Acute Respiratory Distress Syndrome1 , 2002, The Journal of Immunology.

[31]  Ann Richmond,et al.  NF-κB, chemokine gene transcription and tumour growth , 2002, Nature Reviews Immunology.

[32]  M. Kuwano,et al.  ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. , 2002, Cancer research.

[33]  A. Feldman,et al.  Retroviral gene transfer of interferon‐inducible protein 10 inhibits growth of human melanoma xenografts , 2002, International journal of cancer.

[34]  M. Probst-Kepper,et al.  CXCR4/CXCL12 expression and signalling in kidney cancer , 2002, British Journal of Cancer.

[35]  M. Ratajczak,et al.  The SDF‐1‐CXCR4 Axis Stimulates VEGF Secretion and Activates Integrins but does not Affect Proliferation and Survival in Lymphohematopoietic Cells , 2001, Stem cells.

[36]  C. Van Waes,et al.  Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. , 2001, Cancer research.

[37]  D J Mooney,et al.  Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. , 2001, Cancer research.

[38]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[39]  Bernhard Moser,et al.  Lymphocyte traffic control by chemokines , 2001, Nature Immunology.

[40]  M. Burdick,et al.  The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity1 , 2000, The Journal of Immunology.

[41]  E. Hudson,et al.  Differential expression and responsiveness of chemokine receptors (CXCR1–3) by human microvascular endothelial cells and umbilical vein endothelial cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  A. Richmond,et al.  Delayed wound healing in CXCR2 knockout mice. , 2000, The Journal of investigative dermatology.

[43]  M. Burdick,et al.  CXC chemokines in angiogenesis , 2000, Journal of leukocyte biology.

[44]  W. Mitzner,et al.  Angiogenesis in the mouse lung. , 2000, The American journal of pathology.

[45]  A. Sahin,et al.  In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. , 2000, The American journal of pathology.

[46]  M. Burdick,et al.  Secondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses In Vivo1 , 2000, The Journal of Immunology.

[47]  C. Dinney,et al.  Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[48]  M. Burdick,et al.  IL-8 is an angiogenic factor in human coronary atherectomy tissue. , 2000, Circulation.

[49]  Tong-Yuan Yang,et al.  Transgenic Expression of the Chemokine Receptor Encoded by Human Herpesvirus 8 Induces an Angioproliferative Disease Resembling Kaposi's Sarcoma , 2000, The Journal of experimental medicine.

[50]  M. Iannettoni,et al.  The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis. , 2000, Human gene therapy.

[51]  M. Burdick,et al.  IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. , 1999, Journal of immunology.

[52]  C Murdoch,et al.  Cxc chemokine receptor expression on human endothelial cells. , 1999, Cytokine.

[53]  J. Burger,et al.  Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor. , 1999, Journal of immunology.

[54]  Z. Han,et al.  Angiogenesis: state of the art. , 1999, International journal of hematology.

[55]  A. Bikfalvi,et al.  Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. , 1999, Blood.

[56]  S. Abdulla.  Angiogenesis and inflammation , 1999 .

[57]  C. Smith,et al.  Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[58]  M. Burdick,et al.  Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. , 1999, The American journal of pathology.

[59]  M. Burdick,et al.  Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. , 1999, Journal of immunology.

[60]  R. Rabin,et al.  Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. , 1999, Journal of immunology.

[61]  H. Kleinman,et al.  Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Induce Expression of CXCR4 on Human Endothelial Cells: In Vivo Neovascularization Induced by Stromal-Derived Factor-1α , 1999 .

[62]  Thomas N. Kledal,et al.  Agonists and Inverse Agonists for the Herpesvirus 8-encoded Constitutively Active Seven-transmembrane Oncogene Product, ORF-74* , 1999, The Journal of Biological Chemistry.

[63]  P. Borgström,et al.  Recombinant platelet factor 4, an angiogenic marker for human breast carcinoma. , 1998, Anticancer research.

[64]  P. Loetscher,et al.  Lymphocyte‐specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization , 1998, European journal of immunology.

[65]  V. Shyamala,et al.  Interleukin-8 receptors R1 and R2 activate mitogen-activated protein kinases and induce c-fos, independent of Ras and Raf-1 in Chinese hamster ovary cells. , 1998, Biochemistry.

[66]  E. Geras-Raaka,et al.  Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. , 1998, The Journal of clinical investigation.

[67]  S. Rafii,et al.  Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus , 1998, Nature.

[68]  D. Bostwick,et al.  Microvessel density in prostate cancer: prognostic and therapeutic utility. , 1998, Seminars in urologic oncology.

[69]  M. Iannettoni,et al.  Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. , 1998, The Journal of clinical investigation.

[70]  E. Geras-Raaka,et al.  Human Interferon-γ–inducible Protein 10 (IP-10) Inhibits Constitutive Signaling of Kaposi's Sarcoma–associated Herpesvirus G Protein–coupled Receptor , 1998, The Journal of experimental medicine.

[71]  J. Finke,et al.  The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. , 1998, Journal of immunology.

[72]  N. Copeland,et al.  The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[73]  James G. Boyd,et al.  Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3 , 1998, The Journal of experimental medicine.

[74]  Kouji Matsushima,et al.  The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract , 1998, Nature.

[75]  W. Risau.  Angiogenesis is coming of age. , 1998, Circulation research.

[76]  A. Bikfalvi,et al.  Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. , 1998, Blood.

[77]  M. Baggiolini.  Chemokines and leukocyte traffic , 1998, Nature.

[78]  C. Bucana,et al.  Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. , 1998, Journal of the National Cancer Institute.

[79]  G. Trinchieri,et al.  Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. , 1998, The Journal of clinical investigation.

[80]  E. Cesarman,et al.  Erratum: G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.

[81]  E. Cesarman,et al.  Inhibition of Constitutive Signaling of Kaposi's Sarcoma–associated Herpesvirus G Protein–Coupled Receptor by Protein Kinases in Mammalian Cells in Culture , 1998, The Journal of experimental medicine.

[82]  C. Mackay,et al.  The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.

[83]  E. Ohlstein,et al.  Chemokine Receptors in Human Endothelial Cells , 1998, The Journal of Biological Chemistry.

[84]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[85]  P. Moore,et al.  Transcription Mapping of the Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Genome in a Body Cavity-Based Lymphoma Cell Line (BC-1) , 1998, Journal of Virology.

[86]  P. Kristjansen,et al.  Tumor angiogenesis ‐ a new therapeutic target in gliomas , 1998, Acta neurologica Scandinavica.

[87]  E. Cesarman,et al.  G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.

[88]  F. Balkwill,et al.  The molecular and cellular biology of the chemokines , 1998, Journal of viral hepatitis.

[89]  T. Pawson,et al.  Signaling through scaffold, anchoring, and adaptor proteins. , 1997, Science.

[90]  Y. Nakanishi,et al.  Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung. , 1997, Cancer letters.

[91]  W. Wilson,et al.  The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. , 1997, Blood.

[92]  M. Burdick,et al.  Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression , 1997, Journal of leukocyte biology.

[93]  D. Kreutzer,et al.  Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. , 1997, American journal of surgery.

[94]  J. Gershenwald,et al.  Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. , 1997, The American journal of pathology.

[95]  M. Burdick,et al.  Enhanced tumor‐forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth‐regulated cytokine β and γ proteins , 1997 .

[96]  A. Clerk,et al.  Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. , 1997, Cellular signalling.

[97]  R. Whyte,et al.  The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. , 1997, Journal of immunology.

[98]  T. Shono,et al.  Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis , 1997, Molecular and cellular biology.

[99]  Marc Hotfilder1,et al.  Tumorangiogenesis: A Network of Cytokines , 1997, Klinische Padiatrie.

[100]  N. Charan,et al.  Bronchial vascular congestion and angiogenesis. , 1997, The European respiratory journal.

[101]  M. Steurer,et al.  Angiogenesis as a target for tumor treatment. , 1997, Oncology.

[102]  D. Willoughby,et al.  The codependence of angiogenesis and chronic inflammation , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[103]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[104]  J. Teruya-Feldstein,et al.  Mig, the monokine induced by interferon-γ, promotes tumor necrosis in vivo , 1997 .

[105]  J M Pluda,et al.  Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies. , 1997, Seminars in oncology.

[106]  J. Farber.  Mig and IP‐10: CXC chemokines that target lymphocytes , 1997, Journal of leukocyte biology.

[107]  D. Adams,et al.  Chemokines: leucocyte recruitment and activation cytokines , 1997, The Lancet.

[108]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[109]  E. Cesarman,et al.  Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation , 1997, Nature.

[110]  P. Polverini.  How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases. , 1996, European journal of cancer.

[111]  L. Koniaris,et al.  Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[112]  Simon A. Jones,et al.  Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.

[113]  R. Whyte,et al.  Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases , 1996, The Journal of experimental medicine.

[114]  S. Nishikawa,et al.  Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 , 1996, Nature.

[115]  D. Parkinson,et al.  Clinical implications of tumor‐associated neovascularization and current antiangiogenic strategies for the treatment of malignancies of pancreas , 1996, Cancer.

[116]  J. Folkman,et al.  Angiostatin induces and sustains dormancy of human primary tumors in mice , 1996, Nature Medicine.

[117]  M. Burdick,et al.  Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. , 1996, The Journal of clinical investigation.

[118]  K. Norrby.  Interleukin‐8 and de novo mammalian angiogenesis , 1996, Cell proliferation.

[119]  A. Angiolillo,et al.  Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. , 1996, Blood.

[120]  Yung‐Chie Lee,et al.  Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer. , 1995, American journal of respiratory and critical care medicine.

[121]  J. Folkman,et al.  gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice , 1995, The Journal of experimental medicine.

[122]  Armen B. Shanafelt,et al.  The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.

[123]  P. Hansell,et al.  Selective binding of platelet factor 4 to regions of active angiogenesis in vivo. , 1995, The American journal of physiology.

[124]  R. Strieter,et al.  THE ROLE OF CXC CHEMOKINES AS REGULATORS OF ANGIOGENESIS , 1995, Shock.

[125]  P. Leder,et al.  The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation , 1995, The Journal of experimental medicine.

[126]  H. Kleinman,et al.  Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo , 1995, The Journal of experimental medicine.

[127]  G. Neufeld,et al.  Platelet Factor-4 Inhibits the Mitogenic Activity of VEGF121 and VEGF165 Using Several Concurrent Mechanisms (*) , 1995, The Journal of Biological Chemistry.

[128]  D. Kreutzer,et al.  Interleukin-8 expression by head and neck squamous cell carcinoma. , 1995, Archives of otolaryngology--head & neck surgery.

[129]  J. Singh,et al.  Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression , 1994, The Journal of cell biology.

[130]  D. Taub,et al.  Chemokines, inflammation and the immune system. , 1994, Therapeutic immunology.

[131]  C. Bucana,et al.  Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. , 1994, Cancer research.

[132]  R. Whyte,et al.  Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma , 1994, The Journal of experimental medicine.

[133]  V. Dixit,et al.  Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. , 1994, The American journal of pathology.

[134]  M. Baggiolini,et al.  Interleukin-8 and related chemotactic cytokines. The Giles Filley Lecture. , 1994, Chest.

[135]  M. Peão,et al.  Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin , 1994, The Anatomical record.

[136]  K. Pienta,et al.  Tumor-associated angiogenesis in prostate cancer. , 1993, Anticancer research.

[137]  R. Clark.  Basics of cutaneous wound repair. , 1993, The Journal of dermatologic surgery and oncology.

[138]  T. Fan,et al.  Interleukln-8 stimulates angiogenesis in rats , 1993, Inflammation.

[139]  J. Winer,et al.  Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. , 1992, The Journal of biological chemistry.

[140]  R. Strieter,et al.  Interleukin-8. A corneal factor that induces neovascularization. , 1992, The American journal of pathology.

[141]  J. Farber,et al.  A collection of mRNA species that are inducible in the RAW 264.7 mouse macrophage cell line by gamma interferon and other agents , 1992, Molecular and cellular biology.

[142]  J. Folkman,et al.  The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.

[143]  J. Winer,et al.  The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. , 1991, Molecular endocrinology.

[144]  M. Abe,et al.  Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells. , 1990, Biochemical and biophysical research communications.

[145]  R. Michel,et al.  Segmental vascular resistance in postobstructive pulmonary vasculopathy. , 1990, Journal of applied physiology.

[146]  J. Farber.  A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[147]  G. Gray,et al.  Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. , 1990, Science.

[148]  G. Lenoir,et al.  Burkitt's lymphoma cell lines reveal different degrees of tumorigenicity in nude mice , 1988, International journal of cancer.

[149]  J. Ravetch,et al.  Biochemical characterization of a gamma interferon-inducible cytokine (IP-10) , 1987, The Journal of experimental medicine.

[150]  A. Koch,et al.  Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. , 1986, Arthritis and rheumatism.

[151]  Andrew D. Luster,et al.  γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins , 1985, Nature.

[152]  G. Majno,et al.  Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. , 1983, The American journal of pathology.

[153]  H. Shio,et al.  Characterization of Cell Populations Isolated from Aortas of Rhesus Monkeys with Experimental Atherosclerosis , 1980, Circulation research.

[154]  R. Vallance,et al.  Neoplasms of the lung. , 1978, British medical journal.

[155]  E. Unanue,et al.  Activated macrophages induce vascular proliferation , 1977, Nature.

[156]  R. Auerbach,et al.  Angiogenesis induction by tumors, embryonic tissues, and lymphocytes. , 1976, Cancer research.

[157]  R. Engerman,et al.  Cell turnover of capillaries. , 1967, Laboratory investigation; a journal of technical methods and pathology.

[158]  M. Turner‐Warwick.  Precapillary Systemic-pulmonary Anastomoses , 1963, Thorax.

[159]  T. R. Harrison.  Principles of internal medicine , 1955 .

[160]  K. Schlaepfer.  LIGATION OF THE PULMONARY ARTERY OF ONE LUNG WITH AND WITHOUT RESECTION OF THE PHRENIC NERVE: EXPERIMENTAL STUDY , 1924 .

[161]  R. Strieter,et al.  Chemokines: angiogenesis and metastases in lung cancer. , 2004, Novartis Foundation symposium.

[162]  P. Dhawan,et al.  How do chemokine/chemokine receptor activations affect tumorigenesis? , 2004, Novartis Foundation symposium.

[163]  M. Burdick,et al.  Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint. , 2001, Arthritis and rheumatism.

[164]  M. Serio,et al.  Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. , 2001, The Journal of clinical investigation.

[165]  I. Fidler,et al.  Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. , 2001, Neoplasia.

[166]  R. Vessella,et al.  Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. , 1999, Urology.

[167]  G. Gentilini,et al.  Inhibition of human umbilical vein endothelial cell proliferation by the CXC chemokine, platelet factor 4 (PF4), is associated with impaired downregulation of p21(Cip1/WAF1). , 1999, Blood.

[168]  YF Hui,et al.  Angiogenesis inhibitors. A promising role in cancer therapy. , 1998, Cancer practice.

[169]  B. Zetter,et al.  Angiogenesis and tumor metastasis. , 1998, Annual review of medicine.

[170]  S. Kurtzman,et al.  Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. , 1998, Anticancer research.

[171]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[172]  I. Fidler,et al.  Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. , 1998, The American journal of pathology.

[173]  R. Kumar,et al.  Angiogenic molecules and cancer metastasis. , 1998, In vivo.

[174]  J. Zieliński,et al.  Angiogenic activity and interleukin-8 content of human ovarian cancer ascites. , 1998, European journal of gynaecological oncology.

[175]  R. Strieter,et al.  In vitro and in vivo systems to assess role of C-X-C chemokines in regulation of angiogenesis. , 1997, Methods in enzymology.

[176]  N. Charan,et al.  Angiogenesis in bronchial circulatory system after unilateral pulmonary artery obstruction. , 1997, Journal of applied physiology.

[177]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[178]  P. Polverini,et al.  The pathophysiology of angiogenesis. , 1995, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[179]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[180]  R. Auerbach,et al.  Angiogenesis inhibition: a review. , 1994, Pharmacology & therapeutics.

[181]  A. Peruga,et al.  Cardiovascular disease mortality in the Americas. , 1993, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[182]  N. Bouck.  Angiogenesis: a mechanism by which oncogenes and tumor suppressor genes regulate tumorigenesis. , 1992, Cancer treatment and research.

[183]  R. Auerbach,et al.  Assays for angiogenesis: a review. , 1991, Pharmacology & therapeutics.

[184]  R. Cotran,et al.  The pathogenesis of atherosclerosis: atherogenesis and inflammation. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[185]  D. Wiseman,et al.  Macrophages, wound repair and angiogenesis. , 1988, Progress in clinical and biological research.

[186]  A. Fishman.  Pulmonary Diseases and Disorders , 1980 .